[
  {
    "narrative_id": "cidara_therapeutics_narrative_1",
    "entity_id": "cidara_therapeutics",
    "title": "Vaccine Merck Billion Flu",
    "summary": "Vaccine Fatigue ? Merck Bets 9.2 Billion on Not-a-Vaccine Flu Drug Merck will spend 9.2 billion to buy Cidara Therapeutics and lock down an experimental flu-prevention drug the company emphasized is not a vaccine.",
    "taxonomy_label": "Financial Integrity",
    "post_count": 2,
    "risk_score": 68.2,
    "confidence": "medium",
    "confidence_band": [
      53.2,
      83.2
    ],
    "confidence_raw": 0.53,
    "drivers": [
      {
        "name": "Language Signals",
        "score": 75.0,
        "weight": 0.3,
        "contribution": 22.5,
        "detail": {
          "taxonomy_label": "Financial Integrity",
          "taxonomy_base_score": 75,
          "negative_ratio": 0.0,
          "positive_ratio": 0.0,
          "sentiment_modifier": 0.0,
          "high_risk_keywords": 0,
          "medium_risk_keywords": 0,
          "low_risk_keywords": 0,
          "keyword_modifier": 0.0
        }
      },
      {
        "name": "Engagement",
        "score": 100.0,
        "weight": 0.2,
        "contribution": 20.0,
        "detail": {
          "total_weighted_engagement": 76.3,
          "avg_per_post": 38.2,
          "total_shares": 5,
          "total_comments": 1,
          "total_likes": 0,
          "total_views": 593,
          "percentile": 100.0
        }
      },
      {
        "name": "Author Influence",
        "score": 100.0,
        "weight": 0.15,
        "contribution": 15.0,
        "detail": {
          "max_followers": 60595,
          "median_followers": 60595,
          "unique_authors": 2,
          "raw_score": 62.1,
          "percentile": 100.0
        }
      },
      {
        "name": "Volume",
        "score": 50.0,
        "weight": 0.2,
        "contribution": 10.0,
        "detail": {
          "post_count": 2,
          "percentile": 50.0
        }
      },
      {
        "name": "Velocity",
        "score": 4.7,
        "weight": 0.15,
        "contribution": 0.7,
        "detail": {
          "posts_per_day": 0.59,
          "span_days": 3.4,
          "accelerating": true
        }
      }
    ],
    "evidence_posts": [
      {
        "post_id": "1992769850075390391",
        "text": "‚ÄòVaccine Fatigue‚Äô? Merck Bets $9.2 Billion on ‚ÄòNot-a-Vaccine‚Äô Flu Drug\n\nMerck will spend $9.2 billion to buy Cidara Therapeutics and lock down an experimental flu-prevention drug the company emphasized is ‚Äúnot a vaccine.‚Äù \nhttps://t.co/jSGtoEdCSM",
        "url": "https://x.com/i/web/status/1992769850075390391",
        "platform": "twitter",
        "likes": 0,
        "shares": 3,
        "comments": 1,
        "followers": 1,
        "handle": "TavernTruth"
      },
      {
        "post_id": "1991532005566173498",
        "text": "News; $CDTX Merck Is Buying Cidara Therapeutics for $9.2 Billion. Is This the Boost the Lagging Drugmaker Needs? \n\nhttps://t.co/obagIy55tt\n\nFollow for daily #StockNews!\n@grok please provide the finance card for $CDTX",
        "url": "https://x.com/i/web/status/1991532005566173498",
        "platform": "twitter",
        "likes": 0,
        "shares": 2,
        "comments": 0,
        "followers": 60595,
        "handle": "marketwirenews"
      }
    ],
    "sentiment_distribution": {
      "neutral": 2
    }
  },
  {
    "narrative_id": "cidara_therapeutics_narrative_2",
    "entity_id": "cidara_therapeutics",
    "title": "Therapeutics Merck Mrk Nearing",
    "summary": "Merck MRK is nearing a deal to buy Cidara Therapeutics CDTX XBI IBB who s next ? Seres Therapeutics MCRB",
    "taxonomy_label": "Financial Integrity",
    "post_count": 3,
    "risk_score": 62.2,
    "confidence": "medium",
    "confidence_band": [
      47.2,
      77.2
    ],
    "confidence_raw": 0.58,
    "drivers": [
      {
        "name": "Language Signals",
        "score": 75.0,
        "weight": 0.3,
        "contribution": 22.5,
        "detail": {
          "taxonomy_label": "Financial Integrity",
          "taxonomy_base_score": 75,
          "negative_ratio": 0.0,
          "positive_ratio": 0.0,
          "sentiment_modifier": 0.0,
          "high_risk_keywords": 0,
          "medium_risk_keywords": 0,
          "low_risk_keywords": 0,
          "keyword_modifier": 0.0
        }
      },
      {
        "name": "Volume",
        "score": 100.0,
        "weight": 0.2,
        "contribution": 20.0,
        "detail": {
          "post_count": 3,
          "percentile": 100.0
        }
      },
      {
        "name": "Engagement",
        "score": 50.0,
        "weight": 0.2,
        "contribution": 10.0,
        "detail": {
          "total_weighted_engagement": 61.6,
          "avg_per_post": 20.5,
          "total_shares": 0,
          "total_comments": 0,
          "total_likes": 0,
          "total_views": 616,
          "percentile": 50.0
        }
      },
      {
        "name": "Author Influence",
        "score": 50.0,
        "weight": 0.15,
        "contribution": 7.5,
        "detail": {
          "max_followers": 388,
          "median_followers": 1,
          "unique_authors": 3,
          "raw_score": 25.2,
          "percentile": 50.0
        }
      },
      {
        "name": "Velocity",
        "score": 14.4,
        "weight": 0.15,
        "contribution": 2.2,
        "detail": {
          "posts_per_day": 1.79,
          "span_days": 1.7,
          "accelerating": true
        }
      }
    ],
    "evidence_posts": [
      {
        "post_id": "1989259977220132982",
        "text": "Merck $MRK is nearing a deal to buy Cidara Therapeutics $CDTX $XBI $IBB who‚Äôs next ?  Seres Therapeutics üôÉ $MCRB",
        "url": "https://x.com/i/web/status/1989259977220132982",
        "platform": "twitter",
        "likes": 0,
        "shares": 0,
        "comments": 0,
        "followers": 1,
        "handle": "SenefLiveEvents"
      },
      {
        "post_id": "1989865872760959247",
        "text": "Cidara Therapeutics Shares Soar 105% After Merck Agrees To $9.2B Takeover Deal | Nasdaq $CDTX $spx https://t.co/BTvVSPZkaY",
        "url": "https://x.com/i/web/status/1989865872760959247",
        "platform": "twitter",
        "likes": 0,
        "shares": 0,
        "comments": 0,
        "followers": 1,
        "handle": "psshakeer"
      },
      {
        "post_id": "1989618819716022373",
        "text": "Merck to acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental flu prevention drug.",
        "url": "https://x.com/i/web/status/1989618819716022373",
        "platform": "twitter",
        "likes": 0,
        "shares": 0,
        "comments": 0,
        "followers": 388,
        "handle": "baro_jwngma"
      }
    ],
    "sentiment_distribution": {
      "neutral": 3
    }
  }
]